CIK 2106181
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 77.32% | 21 |
| Unclassified | 22.55% | 3 |
| Chemicals | 0.14% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | BOXX | EA SERIES TRUST | Unclassified | 15.06% |
| 2 | XFOR | X4 Pharmaceuticals, Inc | Health Care | 11.83% |
| 3 | SRZN | Surrozen, Inc./DE | Health Care | 8.63% |
| 4 | RLAY | Relay Therapeutics, Inc. | Health Care | 6.90% |
| 5 | SION | Sionna Therapeutics, Inc. | Health Care | 6.08% |
| 6 | MANE | Veradermics, Inc | Health Care | 6.04% |
| 7 | ACRS | Aclaris Therapeutics, Inc. | Health Care | 4.57% |
| 8 | ORKA | Oruka Therapeutics, Inc. | Health Care | 4.47% |
| 9 | PHVS | PHARVARIS N V | Unclassified | 4.32% |
| 10 | IKT | Inhibikase Therapeutics, Inc. | Health Care | 4.20% |
22/25 names classified · sector 77.5% of weight · industry 77.5% · mkt cap 77.5%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 77.5% of the book is sector-classified (unclassified names shown, never dropped).
Only 0% of book weight classified — the grid is NOT representative of the whole book.
Classified: 0.0% of book weight (0/25 names) · unclassified 100.0%: BOXX, XFOR, SRZN, RLAY, SION, MANE, ACRS, ORKA, PHVS, IKT +15 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | BOXXEA SERIES TRUST | 336,700 | $39M | 15.1% | ADD 46% |
| 2 | XFORX4 PHARMACEUTICALS INC | 7,445,680 | $31M | 11.8% | ADD 100% |
| 3 | SRZNSURROZEN INC | 770,356 | $22M | 8.6% | ADD 100% |
| 4 | RLAYRELAY THERAPEUTICS INC | 1,802,914 | $18M | 6.9% | ADD 100% |
| 5 | SIONSIONNA THERAPEUTICS INC | 394,144 | $16M | 6.1% | ADD 100% |
| 6 | MANEVeradermics Inc | 248,574 | $16M | 6.0% | NEW |
| 7 | ACRSACLARIS THERAPEUTICS INC | 3,169,921 | $12M | 4.6% | NEW |
| 8 | ORKAORUKA THERAPEUTICS INC | 237,048 | $12M | 4.5% | ADD 100% |
| 9 | PHVSPHARVARIS N V | 397,544 | $11M | 4.3% | ADD 100% |
| 10 | IKTINHIBIKASE THERAPEUTICS INC | 6,494,498 | $11M | 4.2% | ADD 271% |
| 11 | SEPNSEPTERNA INC | 389,088 | $9M | 3.6% | ADD 100% |
| 12 | CMPSCOMPASS PATHWAYS PLC | 1,639,384 | $9M | 3.5% | ADD 100% |
| 13 | QUREUNIQURE NV | 502,811 | $8M | 3.2% | NEW |
| 14 | LONALEONABIO INC | 787,402 | $8M | 3.1% | ADD 100% |
| 15 | DMRADAMORA THERAPEUTICS INC | 278,000 | $7M | 2.8% | NEW |
| 16 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 351,468 | $7M | 2.5% | ADD 100% |
| 17 | GOSSGOSSAMER BIO INC | 17,708,133 | $6M | 2.2% | NEW |
| 18 | TYRATYRA BIOSCIENCES INC | 148,930 | $6M | 2.2% | ADD 100% |
| 19 | PEPGPEPGEN INC | 1,729,961 | $3M | 1.2% | NEW |
| 20 | TNYATENAYA THERAPEUTICS INC | 4,000,000 | $3M | 1.1% | ADD 100% |
| 21 | TILINSTIL BIO INC | 322,879 | $3M | 1.0% | NEW |
| 22 | KLRSKALARIS THERAPEUTICS INC | 271,170 | $2M | 0.6% | ADD 94% |
| 23 | KRROKORRO BIO INC | 109,376 | $1M | 0.5% | NEW |
| 24 | DMACDIAMEDICA THERAPEUTICS INC | 124,976 | $846,088 | 0.3% | ADD 31% |
| 25 | LOOPLOOP INDS INC | 347,539 | $361,441 | 0.1% | NEW |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| BOXXEA SERIES TRUST | — | — | — | — | 231K | 337K | $39M |
| XFORX4 PHARMACEUTICALS INC | — | — | — | — | 3.7M | 7.4M | $31M |
| SRZNSURROZEN INC | — | — | — | — | 385K | 770K | $22M |
| RLAYRELAY THERAPEUTICS INC | — | — | — | — | 901K | 1.8M | $18M |
| SIONSIONNA THERAPEUTICS INC | — | — | — | — | 197K | 394K | $16M |
| MANEVeradermics Inc | — | — | — | — | — | 249K | $16M |
| ACRSACLARIS THERAPEUTICS INC | — | — | — | — | — | 3.2M | $12M |
| ORKAORUKA THERAPEUTICS INC | — | — | — | — | 119K | 237K | $12M |
| PHVSPHARVARIS N V | — | — | — | — | 199K | 398K | $11M |
| IKTINHIBIKASE THERAPEUTICS INC | — | — | — | — | 1.8M | 6.5M | $11M |
| SEPNSEPTERNA INC | — | — | — | — | 195K | 389K | $9M |
| CMPSCOMPASS PATHWAYS PLC | — | — | — | — | 820K | 1.6M | $9M |
| QUREUNIQURE NV | — | — | — | — | — | 503K | $8M |
| LONALEONABIO INC | — | — | — | — | 394K | 787K | $8M |
| DMRADAMORA THERAPEUTICS INC | — | — | — | — | — | 278K | $7M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
